These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 2935937)
1. Atrial natriuretic peptide elevation in congestive heart failure in the human. Burnett JC; Kao PC; Hu DC; Heser DW; Heublein D; Granger JP; Opgenorth TJ; Reeder GS Science; 1986 Mar; 231(4742):1145-7. PubMed ID: 2935937 [TBL] [Abstract][Full Text] [Related]
2. Dual natriuretic peptide system in experimental heart failure. Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW J Am Coll Cardiol; 1993 Sep; 22(3):891-8. PubMed ID: 8354829 [TBL] [Abstract][Full Text] [Related]
3. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure. Winters CJ; Sallman AL; Baker BJ; Meadows J; Rico DM; Vesely DL Circulation; 1989 Sep; 80(3):438-49. PubMed ID: 2527642 [TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure. Berglund H; Nyquist O; Beermann B; Jensen-Urstad M; Theodorsson E Br Heart J; 1994 Dec; 72(6):521-7. PubMed ID: 7857733 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic factor in the pleural fluid of congestive heart failure patients. Vesely DL; Winters CJ; Sallman AL Chest; 1989 May; 95(5):1107-9. PubMed ID: 2523292 [TBL] [Abstract][Full Text] [Related]
6. Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure. Totsune K; Takahashi K; Murakami O; Satoh F; Sone M; Mouri T Clin Sci (Lond); 1994 Sep; 87(3):319-22. PubMed ID: 7955908 [TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation. Van Den Berg MP; Crijns HJ; Van Veldhuisen DJ; Van Gelder IC; De Kam PJ; Lie KI Am Heart J; 1998 Feb; 135(2 Pt 1):242-4. PubMed ID: 9489971 [TBL] [Abstract][Full Text] [Related]
8. Atrial and brain natriuretic peptides in cardiovascular diseases. Naruse M; Takeyama Y; Tanabe A; Hiroshige J; Naruse K; Yoshimoto T; Tanaka M; Katagiri T; Demura H Hypertension; 1994 Jan; 23(1 Suppl):I231-4. PubMed ID: 8282365 [TBL] [Abstract][Full Text] [Related]
10. The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failure. Edwards BS; Ackermann DM; Schwab TR; Heublein DM; Edwards WD; Wold LE; Burnett JC Mayo Clin Proc; 1986 Jul; 61(7):517-21. PubMed ID: 2423814 [TBL] [Abstract][Full Text] [Related]
11. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. Anderson JV; Woodruff PW; Bloom SR Br Heart J; 1988 Feb; 59(2):207-11. PubMed ID: 2963658 [TBL] [Abstract][Full Text] [Related]
12. Heart with circulatory failure secretes and processes atrial natriuretic peptide in a manner different from normal heart. Matsubara H; Umeda Y; Nishikawa M; Yamane Y; Kurimoto T; Iwasaka T; Inada M Clin Cardiol; 1988 Apr; 11(4):197-203. PubMed ID: 2966690 [TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide in the pericardial fluid of patients with heart disease. Amano J; Suzuki A; Sunamori M; Shichiri M; Marumo F Clin Sci (Lond); 1993 Aug; 85(2):165-8. PubMed ID: 8403785 [TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of the Batista procedure with circulating atrial natriuretic peptides. Weston MW; Vijayangar R; Overton RM; Vesely DL Int J Cardiol; 2000 Jul; 74(2-3):145-52. PubMed ID: 10962114 [TBL] [Abstract][Full Text] [Related]
15. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. Meleagros L; Gibbs JS; Ghatei MA; Bloom SR Br Heart J; 1988 Jul; 60(1):39-44. PubMed ID: 2970269 [TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic factor, cardiac volumes and filling pressures during exercise in congestive heart failure. Donckier JE; De Coster PM; Vanoverschelde JL; Brichant C; Cauwe F; Installe E; Berbinschi A; Ketelslegers JM; Marchandise B Eur Heart J; 1991 Mar; 12(3):332-7. PubMed ID: 1828231 [TBL] [Abstract][Full Text] [Related]
17. [Atrial natriuretic factor and brain natriuretic peptide. Variations in elderly subjects with heart failure]. Tissandier O; Nasr A; Rainfray M; Hamon-Vilcot B; Piette F Presse Med; 1995 Dec; 24(38):1837-41. PubMed ID: 8545437 [TBL] [Abstract][Full Text] [Related]
18. Levels of atrial natriuretic factor in the plasma and urine of patients with and without heart failure. Agnoletti G; Panzali AF; Ferrari R Int J Cardiol; 1993 Jul; 40(2):179-82. PubMed ID: 8394286 [TBL] [Abstract][Full Text] [Related]
19. [Effects of dopamine infusion on the release of atrial natriuretic factor]. Fontana F; Ruffini M; Capelli M; Bernardi P G Ital Cardiol; 1990 Mar; 20(3):227-35. PubMed ID: 2140554 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels of atrial natriuretic peptide and hemodynamic function in cardiac disease. Morici ML; Di Marco A; Traina M; Hoffmann E Int J Cardiol; 1993 Nov; 42(1):15-20. PubMed ID: 8112901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]